Headline
The latest stories from AHA Today.
A district court judge in Texas today vacated nationwide an Affordable Care Act requirement that most group and individual health plans cover certain preventive health services without cost sharing. The Biden Administration is expected to appeal the ruling.
The Centers for Medicare & Medicaid Services yesterday released FAQs on COVID-19 coverage after the public health emergency ends.
Responding yesterday to a Senate Health, Education, Labor and Pensions Committee request for input on reauthorization of the Pandemic and All-Hazards Preparedness Act, AHA recommended actions to update the federal organizational structure and approach to data collection; strengthen the medical…
The Mississippi Hospital Association Cares Fund, created in the aftermath of Hurricane Katrina, is accepting donations to help Mississippi hospital employees directly affected by the recent tornado.
Learn how Advocate Children's Hospital is managing the “immunity gap” created by social distancing to persevere through the triple threat of COVID-19, RSV and flu.
A recent Washington Post article on medical debt “missed a major reason that medical debt has increased in our country: the rise of high-deductible and skinny insurance plans that result in larger out-of-pocket expenses for consumers,” writes AHA President and CEO Rick Pollack in a letter to the…
In a blog published today, AHA refuted a number of suggestions that appeared in a recent Health Affairs column discussing what is behind the financial losses at large nonprofit hospitals.
The 6th Circuit Court of Appeals yesterday affirmed a district court’s decision dismissing a lawsuit that sought to turn a hospital’s decision not to hire a physician into a False Claims Act suit based on the Anti-Kickback Statute.
AHA President and CEO Rick Pollack today took part in a Kaiser Permanente launch of a new initiative (LINK) to help expand support for public health.
In response to Drug Enforcement Administration proposals to limit telehealth prescriptions for buprenorphine and other controlled substances after the COVID-19 public health emergency to a 30-day supply unless the prescriber or referring clinician have evaluated the patient in person, AHA today…